PERSANTIN

This brand name is authorized in Austria, Brazil, Cyprus, Spain, Finland, Hong Kong, Croatia, Japan, Mexico, Netherlands, Singapore, South Africa

Active ingredients

The drug PERSANTIN contains one active pharmaceutical ingredient (API):

1 Dipyridamole UNII 64ALC7F90C - DIPYRIDAMOLE

Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation. Read about Dipyridamole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Persantin 100 mg Tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC07	Dipyridamole	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 596221080000417
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 56981
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 105197
Country: HK	Department of Health Drug Office	Identifier(s): 02701
Country: JP	医薬品医療機器総合機構	Identifier(s): 2171010F1409, 2171010F2553, 2171010F3053
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 53988, 86077
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 25763
Country: SG	Health Sciences Authority	Identifier(s): 00206P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/8/0400